BioCardia’s (BCDA) “Buy” Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of BioCardia (NASDAQ:BCDA – Free Report) in a research report released on Wednesday morning,Benzinga reports. The firm currently has a $25.00 target price on the stock. BioCardia Price Performance Shares of BCDA opened at $1.97 on Wednesday. The stock has a 50-day moving average of $2.30 and [...]

featured-image

HC Wainwright reissued their buy rating on shares of BioCardia ( NASDAQ:BCDA – Free Report ) in a research report released on Wednesday morning, Benzinga reports. The firm currently has a $25.00 target price on the stock.

BioCardia Price Performance Shares of BCDA opened at $1.97 on Wednesday. The stock has a 50-day moving average of $2.



30 and a 200-day moving average of $2.76. BioCardia has a one year low of $1.

63 and a one year high of $10.79. The company has a market cap of $9.

02 million, a PE ratio of -0.47 and a beta of 1.25.

BioCardia Company Profile ( Get Free Report ) Further Reading Five stocks we like better than BioCardia 3 REITs to Buy and Hold for the Long Term Opal Fuels CEO on Steering the Future of Renewable Natural Gas Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win Manufacturing Stocks Investing 2 Underrated Quantum Computing Companies Starting to Rally Receive News & Ratings for BioCardia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCardia and related companies with MarketBeat.com's FREE daily email newsletter ..